Andrea Loewen-Rodriguez
Corporate Officer/Principal bei Retrophin Pharmaceutical, Inc.
Profil
Andrea Loewen-Rodriguez is currently the Head-Global Regulatory Affairs at Shire Pharmaceuticals, Inc. and the Vice President-Global Regulatory Affairs at Retrophin Pharmaceutical, Inc. She previously worked as the Senior Director-Regulatory Affairs at Ceregene, Inc. from 2008 to 2009, Vice President-Global Regulatory Affairs at Reata Pharmaceuticals, Inc. from 2020 to 2023, Vice President-Global Regulatory Affairs & Quality at Vital Therapies, Inc., and Vice President-Global Regulatory Affairs & Quality at Travere Therapeutics, Inc. from 2017 to 2020.
She received her undergraduate degree from Gustavus Adolphus College and her graduate degree from Pepperdine University.
Aktive Positionen von Andrea Loewen-Rodriguez
| Unternehmen | Position | Beginn |
|---|---|---|
Retrophin Pharmaceutical, Inc.
 Retrophin Pharmaceutical, Inc. BiotechnologyHealth Technology Part of Travere Therapeutics, Inc., Travere Therapeutics Pharmaceutical, Inc. is an American company that engages in the development of drugs for the treatment of debilitating and often life-threatening diseases. The company is based in DE. | Corporate Officer/Principal | - |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | General Counsel | - |
Ehemalige bekannte Positionen von Andrea Loewen-Rodriguez
| Unternehmen | Position | Ende |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | General Counsel | 26.09.2023 |
| TRAVERE THERAPEUTICS, INC. | General Counsel | 01.01.2020 |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | General Counsel | 01.06.2009 |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | General Counsel | - |
Ausbildung von Andrea Loewen-Rodriguez
| Gustavus Adolphus College | Undergraduate Degree |
| Pepperdine University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Ceregene, Inc.
Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
Retrophin Pharmaceutical, Inc.
Retrophin Pharmaceutical, Inc. BiotechnologyHealth Technology Part of Travere Therapeutics, Inc., Travere Therapeutics Pharmaceutical, Inc. is an American company that engages in the development of drugs for the treatment of debilitating and often life-threatening diseases. The company is based in DE. | Health Technology |